463936-45-0Relevant academic research and scientific papers
Diaryl substituted pyrrolidinones and pyrrolones as 5-HT2C inhibitors: Synthesis and biological evaluation
Micheli, Fabrizio,Pasquarello, Alessandra,Tedesco, Giovanna,Hamprecht, Dieter,Bonanomi, Giorgio,Checchia, Anna,Jaxa-Chamiec, Albert,Damiani, Federica,Davalli, Silvia,Donati, Daniele,Gallotti, Chiara,Petrone, Marcella,Rinaldi, Marilisa,Riley, Graham,Terreni, Silvia,Wood, Martyn
, p. 3906 - 3912 (2008/12/21)
Within the continuous quest for the discovery of novel compounds able to treat anxiety and depression, the generation of a pharmacophore model for 5-HT2C receptor antagonists and the discovery of a new class of potent and selective 5-HT2C
COMPOUNDS HAVING AFFINITY AT 5HT2C RECEPTOR AND USE THEREOF IN THERAPY
-
Page/Page column 18, (2008/06/13)
Compounds of formula (I) or a pharmaceutically acceptable salt thereof are disclosed: wherein R1 is hydrogen, hydroxy, fluoro, chloro, C1-6alkyl, C3-7cycloalkyl, C3-7cycloalkyloxy, C1-6alkoxy or haloC
ARYL AND BIARYL COMPOUNDS HAVING MCH MODULATORY ACTIVITY
-
, (2008/06/13)
In one embodiment, this invention provides a novel class of compounds as antagonists of the MCH receptor, methods of preparing such compounds, pharmaceutical compositions containing one or more of the compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention or amelioration or one or more of diseases associated with the MCH receptor. An illustrative inventive compound is shown below:
